-
Study Says IPF Patients Older Than 75 Are More Likely to Stop Taking Esbriet
Director of Multichannel Content for Pulmonary Fibrosis News, Michael Morale, discusses a Japanese study that suggests IPF patients older than 75 are more likely to stop taking Esbriet because of adverse reactions.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.